Search Results for: Catalent to Develop Softgel Capsules
Articles
Catalent to Develop Softgel Capsules for JOT's Leading Orphan Disease Candidates January 9, 2017
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...Catalent Supports US Launch of Phathom Pharmaceuticals' New Products Following Regulatory Approval June 9, 2022
Catalent welcomed the recent announcement by Phathom Pharmaceuticals the US FDA has approved both VOQUEZNA TRIPLE PAK (vonoprazan tablets, amoxicillin...Catalent Invests $175 Million to Expand Manufacturing Capabilities & Capacity May 19, 2022
Catalent recently announced that it has commenced a $175 million project to expand its flagship US manufacturing facility for large...Catalent Signs Commercial Supply Agreement With Phathom Pharmaceuticals September 16, 2021
Catalent recently announced it has signed a commercial supply agreement with Phathom Pharmaceuticals, a late clinical-stage biopharmaceutical company focused on...Catalent Announces Commercial Supply Agreement With Aurinia Pharmaceuticals February 24, 2021
Catalent recently announced it recently signed a multi-year commercial supply agreement with Aurinia Pharmaceuticals, a biopharmaceutical company focused on delivering...Catalent Launches Delayed/Enteric-Release Softgel for Pharmaceutical & Nutraceutical Applications October 22, 2020
Catalent recently announced the launch of OptiGel DR technology for the formulation and manufacture of delayed/enteric-release softgels. The technology allows...Catalent Partners With ViralClear Pharmaceuticals on Potential Treatment for COVID-19 June 23, 2020
Catalent recently announced it has signed an agreement with ViralClear Pharmaceuticals, Inc. to work on the development of a potential...DRUG DEVELOPMENT - Softgel Technology for Fast-Tracked Development Programs April 29, 2019
Jeff Browne, PhD, and Ronak Savla, PharmD, PhD, believe given the accelerated timelines associated with expedited programs, lipid-based drug formulations, encapsulated in softgel capsules, provide an attractive option for addressing the challenges facing formulators.
Catalent Invests $14 Million at its Softgel Facility April 25, 2019
Catalent recently announced that work is underway to expand integrated turnkey softgel capabilities at its facility in Eberbach, Germany. The...SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine June 6, 2018
Contributor Cindy H. Dubin speaks with some of the industry’s leading CDMOs about the innovations they are developing for next-generation patient care, and how many are making investments that are enabling them to offer more services under one roof.
SPECIAL FEATURE - Challenging Molecules Drive Developers to Get More Creative With Excipients April 2, 2018
Contributor Cindy H. Dubin highlights the techniques various excipient manufacturers are using to develop more innovative and effective ingredients to improve the performance of drug molecules.
Pfizer Partners With Catalent for Exclusive Long-Term Supply Agreement July 12, 2017
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer...Catalent's Proprietary Softgel Technology Used to Provide Daily Dosing of Modified-Release Semi-Solid Formulation August 10, 2015
Catalent Pharma Solutions recently welcomed the announcement by OPKO Health that the US Food and Drug Administration has accepted for...Catalent Acquires Pharmapak, Australia April 6, 2015
Catalent Pharma Solutions recently announced it has acquired Pharmapak Technologies Pty Ltd., a leading pharmaceutical packaging business based in New...Catalent Expands Integrated Softgel Operations January 26, 2015
Catalent Pharma Solutions recently announced it will add new coating and blister packaging equipment at its 360,000-sq-ft, Eberbach, Germany, softgel...FORMULATION DEVELOPMENT - Interactive Web Tool Helps Innovators Match Formulations to Drug Delivery Technologies January 7, 2015
Kurt Nielsen, PhD, explains how an interactive web tool designed to help innovators match formulations to drug delivery challenges allows users to assess multiple oral drug delivery technologies in order to establish which may be the most appropriate for their molecule.
Catalent Marks 40 Years in Japan July 8, 2014
Catalent Pharma Solutions, now in its 40th year in the Japanese market, recently announced that it has appointed Tadahiro Matsumura...Catalent Continues Major Growth Drive With Latest Acquisition Into Emerging Markets October 14, 2013
Catalent Pharma Solutions recently announced the acquisition of Relthy Laboratórios in Brazil. Catalent continues to build upon its global leadership...SPECIAL FEATURE - Analytical Testing: Using More Sophisticated Tools to Support Small & Large Molecule Projects January 8, 2016
Contributor Cindy H. Dubin recently spoke with leading analytical testing providers to find out what services they offer and what equipment they use to handle both small and large molecules for their pharma clients.
HOT MELT EXTRUSION - OptiMelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs August 31, 2015
Sampada Upadhye, PhD, indicates bioavailability enhancement with formulation and dose form flexibility can be achieved through the application of HME technology to produce stable drug formulations and increased development success rates.
